medical glp 1 weight loss Effective GLP-1 Long-term Success of GLP-1s Hinges

S., Williamson, D., & Yanovski, S

PMID: 93 SchoelerMCaesarR

Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation

Hiramatsu, T

This guide consolidates the available preclinical data into a realistic, week-by-week reference organized by tissue type, with the caveats front and center

In weight loss trials, participants on the highest dose (2.4 mg) lost more than 15% of their body weight by week 48